Stockreport

Sutro Biopharma (STRO) Rises 9% in the Past Week: Here's Why [Yahoo! Finance]

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report
PDF development platforms to treat several oncology indications. The company's pipeline comprises only one candidate, luveltamab tazevibulin or luvelta (formerly known as ST [Read more]